Stock BIONDVAX PHARMACEUTICALS LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Biondvax Pharmaceuticals Ltd Share Price Other OTC

Equities

Biotechnology & Medical Research

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Chart Biondvax Pharmaceuticals Ltd

Dynamic Chart

Press releases Biondvax Pharmaceuticals Ltd

Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million PU
Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial PU
Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million PU
Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan PU
Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process PU
More press releases

Managers and Directors - Biondvax Pharmaceuticals Ltd

Managers TitleAgeSince
Amir Reichman CEO
 Chief Executive Officer 49 02/21/02
Uri Ben-Or DFI
 Director of Finance/CFO 52 01/07/01
Dalit Weinstein Fischer CTO
 Chief Tech/Sci/R&D Officer - 01/22/01
Members of the board TitleAgeSince
Adi Raviv BRD
 Director/Board Member 69 24/20/24
Samuel Moed BRD
 Director/Board Member 62 24/20/24
Morris Laster BRD
 Director/Board Member 60 27/17/27
More insiders

Company Profile

More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+23.37% 47.02B
LONZA GROUP AG Stock Lonza Group AG
+48.83% 41.86B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.94% 41.76B
CELLTRION, INC. Stock Celltrion, Inc.
-5.86% 28.8B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.29% 26.05B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.92% 19.15B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+3.20% 12.55B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.67% 11.82B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.23% 12.34B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW